A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results

David A. Wohl, Calvin Cohen, Joel E. Gallant, Anthony Mills, Paul E. Sax, Edwin Dejesus, Andrew Zolopa, Hui C. Liu, Andrew Plummer, Kirsten L. White, Andrew K. Cheng, Martin S. Rhee, Javier Szwarcberg

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
JournalJournal of Acquired Immune Deficiency Syndromes
Volume65
Issue number3
DOIs
StatePublished - Mar 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this